News-Papers
Testimonial
Video Gallery
Glioma, melatonin, and radiotherapy
Published on Wednesday, 20 April 2016
Glioma, melatonin, and radiotherapy
About this Letter to the Editor.
See also:
- Complete objective response to biological therapy of plurifocal breast carcinoma.
Search
Follow us...
Latest
- Melatonin: The smart molecule that differentially modulates autophagy in tumor and normal placental cells
- Melatonin Alleviates Radiation-Induced Lung Injury via Regulation of miR-30e/NLRP3 Axis
- Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial
- Pan-cancer Genomic Analyses Reveal Prognostic and Immunogenic Features of the Tumor Melatonergic Microenvironment Across 14 Solid Cancer Types
- PK-PD based optimal dose and time for orally administered supra-pharmacological dose of melatonin to prevent radiation induced mortality in mice
- Acromegaly associated with GIST, non-small cell lung cancer, clear cell renal cancer, myeloma multiplex, medulla oblongata tumor, adrenal adenoma and follicular thyroid nodules
- Ascorbic acid and beta-carotene as modulators of oxidative damage
- Prospective study of serum selenium levels and incident esophageal and gastric cancers
- Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits
- Vitamin E: Regulatory Role on Signal Transduction
- Vitamin E enhances the chemotherapeutic effects of adriamycin on human prostatic carcinoma cells in vitro
- Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation
- Lack of tocopherol in peripheral nerves of vitamin E-deficient patients with peripheral neuropathy
- Dietary vitamin E intake could reduce the risk of lung cancer: evidence from a meta-analysis
- Tocopherol and local X-ray irradiation of two transplantable rat tumours
- Chemopreventive effects of early-stage and late-stage supplementation of vitamin E and selenium on esophageal carcinogenesis in rats maintained on a low vitamin E/selenium diet
- Expression of GHRH-R, a Potentially Targetable Biomarker, in Triple-negative Breast Cancer
- RNA-Seq transcriptome analysis shows anti-tumor actions of melatonin in a breast cancer xenograft model
Most Read
- All-trans-retinoic acid and cancer
- The Di Bella Method (DBM)
- Biography
- About melatonin - 1996
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Bibliography
- Somatostatin in oncology, the overlooked evidences
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Vademecum
- Frequently Asked Questions
- How effective is chemo therapy?
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
- Novel synergistic mechanism for sst2 somatostatin and TNFalpha receptors to induce apoptosis: crosstalk between NF-kappaB and JNK pathways